4.4 Article

RANBP2 mutation causing autosomal dominant acute necrotizing encephalopathy attenuates its interaction with COX11

Journal

NEUROSCIENCE LETTERS
Volume 763, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2021.136173

Keywords

Autosomal dominant acute necrotizing encephalopathy; Ran-binding protein 2; Cytochrome c oxidase copper chaperone; COX11; Mitochondrial dysfunction; Energy failure

Categories

Funding

  1. National Insti-tute of Public Health, Japan [H30-Nanji-Ippan-007]
  2. Japan Society for the Promotion of Science [15H04872]
  3. Grants-in-Aid for Scientific Research [15H04872] Funding Source: KAKEN

Ask authors/readers for more resources

The study found that mutated RANBP2 in ADANE patients has a weaker binding ability to COX11 compared to the wild-type RANBP2, which may affect the production of ATP, further research is needed to confirm this.
Purpose: Autosomal dominant acute necrotizing encephalopathy (ADANE) is caused by missense mutations in the gene encoding Ran-binding protein 2 (RANBP2), a nuclear pore protein regulating mitochondrial localization and function. Previous studies have found that RANBP2 binds to COX11 and suppresses its inhibitory activity over hexokinase1. To further elucidate mitochondrial dysfunction in ADANE, we analyzed the interaction between mutated RANBP2 and COX11. Methods: We extracted cDNA from a patient and constructed pGEX wild-type or mutant-type vectors including RANBP2 c.1754C>T, the commonest variant in ADANE. We transformed E. coli competent cells with the vectors and had them express GST-RANBP2 recombinant protein, and conducted a pull-down assay of RANBP2 and COX11. Results: The amount of COX11 bound to mutated RANBP2 was significantly smaller than that bound to the wild-type RANBP2. Conclusion: Mutated RANBP2 had an attenuated binding ability to COX11. Whether this change indeed decreases ATP production remains to be further explored.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available